# Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

> **NCT00936143** · PHASE4 · COMPLETED · sponsor: **Gu Jieruo** · enrollment: 70 (actual)

## Conditions studied

- Spondylitis

## Interventions

- **DRUG:** infliximab

## Key facts

- **NCT ID:** NCT00936143
- **Lead sponsor:** Gu Jieruo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936143, "Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00936143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*